---
title: "SoftMedx Avoids HK$412 Million Fair Value Loss and Posts 2025 Profit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280830282.md"
description: "SoftMedx Healthcare Limited has avoided a HK$412 million fair value loss for the year ending December 31, 2025, which was not recognized in its financial statements. The company reported a net profit of HK$10 million from ordinary operations and an overall net profit of HK$7 million for 2025. This announcement alleviates previous investor concerns following a profit warning. SoftMedx advises shareholders to review its full annual results and exercise caution in trading its shares. The company is part of China Wah Yan Healthcare and operates in the healthcare sector."
datetime: "2026-03-27T17:27:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280830282.md)
  - [en](https://longbridge.com/en/news/280830282.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280830282.md)
---

# SoftMedx Avoids HK$412 Million Fair Value Loss and Posts 2025 Profit

### Claim 30% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

China Wah Yan Healthcare ( (HK:0648) ) just unveiled an update.

SoftMedx Healthcare Limited has clarified that a previously expected one-off fair value loss of about HK$412 million for the year ended 31 December 2025 was ultimately not recognized in its financial statements under applicable accounting standards. The company stressed that this change has no impact on its balance sheet, cash flow or net asset value, easing concerns that had been raised by an earlier profit warning.

For 2025, the group reported a net profit of HK$10 million from its ordinary operations excluding exceptional items and an overall net profit of HK$7 million. The announcement signals a significantly more stable financial outcome than investors had feared, though the company still urges shareholders and potential investors to review its full annual results and exercise caution when trading its shares.

**More about China Wah Yan Healthcare**

SoftMedx Healthcare Limited is a Hong Kong-listed healthcare group. The company operates through its subsidiaries, focusing on healthcare-related businesses and services, and is overseen by a board comprising an executive director and several independent non-executive directors.

**Average Trading Volume:** 2,231,369

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$552.8M

### Related Stocks

- [00648.HK](https://longbridge.com/en/quote/00648.HK.md)

## Related News & Research

- [15:45 ET"Lean" Strengthens Saudi Arabia's Presence in Global Digital Health and Precision Medicine Ecosystems](https://longbridge.com/en/news/286811787.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [Hong Kong’s MPF authority flags fraudulent certificates in early pension payouts](https://longbridge.com/en/news/286657515.md)
- [UAE among first globally to approve new obesity, hypertension treatments](https://longbridge.com/en/news/286707352.md)
- [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md)